STAT

‘Therabros’ and ‘disappeared’ staffers: the 8 juiciest things we learned from John Carreyrou’s new Theranos book

'Therabros' and 'disappeared' staffers: the 8 juiciest things we learned from John Carreyrou's new Theranos book.
Theranos CEO Elizabeth Holmes

Theranos this week laid off all but about two dozen of its remaining employees — the latest indignity for the once fabulously rich blood-testing company that’s become a parable for Silicon Valley hubris.

As with much of the flood of bad news for Theranos, word of the layoffs came from John Carreyrou, the investigative reporter at the Wall Street Journal who was the first to break the story of the company’s troubles in October 2015 and who later landed a string of Theranos-related scoops.

Carreyrou also happens to be the author of a new book on the company, “Bad Blood: Secrets and Lies in a Silicon Valley Startup,” which is being released on May 21. The first print, from the publishing house Alfred A. Knopf, will be 100,000 copies.

STAT obtained an advance copy

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks